Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v30-EN | Version v20-EN | |
---|---|---|
Language | English | English |
Date Updated | 2018-11-27 | 2018-09-28 |
Drug Identification Number | 00781878 | 00781878 |
Brand name | VITAMIN K1 INJ 1MG/0.5ML USP | VITAMIN K1 INJ 1MG/0.5ML USP |
Common or Proper name | VITAMIN K1 2MG/ML | VITAMIN K1 2MG/ML |
Company Name | SANDOZ CANADA INCORPORATED | SANDOZ CANADA INCORPORATED |
Ingredients | VITAMIN K1 | VITAMIN K1 |
Strength(s) | 2MG | 2MG |
Dosage form(s) | EMULSION | EMULSION |
Route of administration | INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS | INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS |
Packaging size | 10 x 0.5mL amps | 10 x 0.5mL amps |
ATC code | B02BA | B02BA |
ATC description | VITAMIN K AND OTHER HEMOSTATICS | VITAMIN K AND OTHER HEMOSTATICS |
Reason for shortage | Delay in shipping of the drug. | Delay in shipping of the drug. |
Anticipated start date | ||
Actual start date | 2018-07-09 | 2018-07-09 |
Estimated end date | 2018-12-07 | 2018-10-01 |
Actual end date | 2018-11-26 | |
Shortage status | Resolved | Actual shortage |
Tier 3 Status | No | No |
Company comments | To maintain our inventory levels and to avoid unanticipated bulk orders, the products will be placed on protective allocation at 200% of historical monthly volumes at this time. Baxter Product. | Baxter has limited the release of these products and placed them on allocation at 200% of historical usage during this shortage and will continue to monitor inventory until the issue is resolved. |
Health Canada comments |